Concord Drugs Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 16.99 | 10.28 | 13.61 | 10.40 | 10.80 |
| Other Income Qtr Cr | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenues Qtr | 16.97 | 10.28 | 13.61 | 10.39 | 10.80 |
Loading chart... | |||||
Operating Expenses Qtr | 16.04 | 9.18 | 12.59 | 9.35 | 9.41 |
Operating Profit Qtr | 0.92 | 1.10 | 1.02 | 1.04 | 1.39 |
EBITDA Qtr Cr | 0.94 | 1.10 | 1.02 | 1.05 | 1.39 |
Depreciation Qtr | 0.31 | 0.34 | 0.37 | 0.38 | 0.37 |
Net Profit Qtr | 0.22 | 0.19 | 0.12 | 0.04 | 0.23 |
Basic EPS Qtr | 0.16 | 0.19 | 0.12 | 0.04 | 0.23 |
Open Demat Account